Fraunhofer IBMT is interested in establishing balanced R&D collaborations with Japanese partners within the framework of Bioeconomy International 2027 (Module Germany–Japan).
The institute seeks joint projects that contribute to sustainable bioeconomy solutions and next‑generation biomanufacturing, in particular in:
- Development and optimization of bio‑based production processes
- Process integration, automation and upscaling for industrial biotechnology
- Platform technologies enabling efficient and sustainable biomanufacturing
- Joint development of innovative bio‑based products with enhanced functionality and sustainability
We offer:
- Extensive experience in applied research and technology development
- Proven track record in international collaborative projects
- Strong competence in engineering‑driven solutions for biotechnology and bioeconomy
- Access to advanced laboratory infrastructure, automation technologies and pilot‑scale concepts
- Support for technology transfer and industrial implementation
The Fraunhofer Institute for Biomedical Engineering (IBMT) is an applied research institute of the Fraunhofer‑Gesellschaft with headquarters in Sulzbach (Germany). Operating in the international growth markets of life sciences, biotechnology and (bio)medical engineering, Fraunhofer IBMT develops technologies, processes and systems along the entire innovation chain – from concept to application and technology transfer.
The institute combines engineering, biotechnology and medical expertise and works closely with industrial, academic and public partners worldwide.
Fraunhofer IBMT’s strategy focuses on the following core areas:
- Biotechnology and bioprocess engineering, including automated and scalable laboratory technologies
- Development of bio‑based and biohybrid systems, biomaterials and functionalized materials
- Intelligent sensors and ultrasound technologies for biotechnological and industrial applications
- Process development, automation and integration for laboratory and biomanufacturing environments
- Biobanking, cryotechnology and stem cell process engineering
- Digital and data‑driven technologies supporting life sciences and healthcare applications
These competences enable Fraunhofer IBMT to address both biological and engineering challenges in bio‑based value chains and advanced biomanufacturing